Clinico-Epidemiological Profile, Incidence, Predictors and outcomes of Acute Kidney Injury in Pediatric Snakebite Envenomation: A Prospective Observational Study From North India
Introduction:
Snakebite envenoming is a neglected tropical disease that falls disproportionately on children in rural, agrarian parts of the tropics, and India carries the largest share of the global mortality. Acute kidney injury (AKI) is among the most important complications of envenomation, but paediatric data from North India remain sparse. This study describes the clinico-epidemiological profile of snakebite in children at a tertiary-care centre in Jammu and reports the incidence, predictors, and short-term outcomes of AKI.
Materials and methods:
This prospective observational study enrolled 142 children aged one to 17 years admitted with snakebite or symptoms of envenomation between 1 May 2024 and 30 April 2025. Demographic, clinical, laboratory, and treatment data were recorded on a structured proforma. AKI was defined by the Kidney Disease: Improving Global Outcomes (KDIGO) 2012 criteria. Survivors were followed for three months for residual renal and neurological deficits. Categorical variables were compared using the chi-square or Fisher's exact test, and multivariate logistic regression was used to identify independent predictors of AKI.
Results:
Most children were older than five years (115, 80.99%) and male (87, 61.27%); 96 (67.61%) came from rural areas and 112 (78.87%) presented between June and September. Fang marks (123, 86.62%) and local swelling (96, 67.61%) were the commonest findings, and the offending snake could not be identified in 67 children (47.18%). AKI developed in 54 children (38.03%), most often KDIGO stage 1 (32 of 54, 59.26%); four children (2.82%) required hemodialysis and four (2.82%) died. On multivariate analysis, hematotoxic envenomation (adjusted odds ratio [OR] 8.87, 95% CI 1.27-62.05), urinary albumin 2+ (OR 66.66, 95% CI 3.33-1336.06), and receipt of anti-snake venom, whether 10 vials (OR 30.10, 95% CI 1.74-519.96) or 20 vials (OR 15.83, 95% CI 1.35-185.41), were independently associated with AKI. At three months, two of 73 children assessed (2.74%) had persistent renal impairment and two of 38 (5.26%) had neurological sequelae.
Conclusions:
AKI complicated more than a third of paediatric snakebites in this North Indian cohort, yet short-term outcomes were favourable, with low mortality and infrequent residual renal or neurological deficit. Hematotoxic envenomation, albuminuria, and a higher anti-snake venom requirement identified children who warrant closer renal monitoring, although the wide confidence intervals around these estimates reflect the modest number of events